Skip to main content
. 2018 Dec 20;2018(12):CD007964. doi: 10.1002/14651858.CD007964.pub2

Fohlmann 2010.

Methods Allocation: randomised
Blinding: not reported
Duration: not reported
Location: not reported
Length of follow‐up: not reported
Participants Diagnosis: a diagnosis with schizophrenic spectrum disorder (F2, ICD‐10) and co‐occurring cannabis abuse (F12, ICD‐10)
Total: N = 103
Sex: not reported
Age: not reported
Length of illness: not reported
Inclusion criteria: not reported
Exclusion criteria: not reported
Interventions 1. Motivational Interviewing (MI) and Cognitive Behavioural Therapy (CBT) group
 2. Standard care (treatment‐as‐usual) group
Outcomes Awaiting full text
Notes Awaiting full text